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Tumor Necrosis Factor-a-Activated Human Adipose
Tissue–Derived Mesenchymal Stem Cells Accelerate
Cutaneous Wound Healing through Paracrine
Mechanisms
Soon Chul Heo1,2, Eun Su Jeon3, Il Hwan Lee1,2, Hoon Soo Kim4, Moon Bum Kim4 and Jae Ho Kim1,2
Human adipose tissue–derived mesenchymal stem cells (ASCs) stimulate regeneration of injured tissues by
secretion of various cytokines and chemokines. Wound healing is mediated by multiple steps including
inflammation, epithelialization, neoangiogenesis, and proliferation. To explore the paracrine functions of ASCs
on regeneration of injured tissues, cells were treated with tumor necrosis factor-a (TNF-a), a key inflammatory
cytokine, and the effects of TNF-a-conditioned medium (CM) on tissue regeneration were determined using a
rat excisional wound model. We demonstrated that TNF-a CM accelerated wound closure, angiogenesis,
proliferation, and infiltration of immune cells into the cutaneous wound in vivo. To assess the role
of proinflammatory cytokines IL-6 and IL-8, which are included in TNF-a CM, IL-6 and IL-8 were depleted
from TNF-a CM using immunoprecipitation. Depletion of IL-6 or IL-8 largely attenuated TNF-a CM-stimulated
wound closure, angiogenesis, proliferation, and infiltration of immune cells. These results suggest
that TNF-a-activated ASCs accelerate cutaneous wound healing through paracrine mechanisms involving
IL-6 and IL-8.
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INTRODUCTION
Wound healing is not a series of individual and independent
progressive steps, but a complex process involving inflam-
mation, epithelialization, neoangiogenesis, proliferation,
and collagen matrix formation (Singer and Clark, 1999).
This complex process is carried out and regulated by
numerous growth factors, cytokines, and chemokines such
as epidermal growth factor, transforming growth factor-b,
platelet-derived growth factor, fibroblast growth factor,
vascular endothelial growth factor, granulocyte macrophage
colony-stimulating factor, IL family, and tumor necrosis
factor-a (TNF-a; Steenfos, 1994; Goldman, 2004; Barrientos
et al., 2008). Local or topical application of growth factors
and cytokines has been reported to promote repair of chronic
wounds (Braund et al., 2007).
Mesenchymal stem cells (MSCs) are multipotent stem
cells that can differentiate into diverse cell types, including
adipocytes, osteoblasts, chondrocytes, and smooth
muscle cells (Pittenger et al., 1999; Short et al., 2003; Caplan
and Dennis, 2006). They can be isolated from a variety
of tissues, such as bone marrow, periosteum, trabecular bone,
synovium, skeletal muscle, deciduous teeth, and adipose
tissues (da Silva et al., 2006). MSCs accelerated wound
healing in several animal models by stimulation of wound
closure, re-epithelialization, cellularity, and angiogenesis
(Fu et al., 2006; McFarlin et al., 2006; Wu et al., 2007).
MSCs have been reported to stimulate tissue regeneration
and wound repair by direct differentiation of MSCs to tissue
cells or secretion of paracrine factors (Gnecchi et al.,
2008; Hocking and Gibran, 2010; Wu et al., 2010).
However, an increasing body of evidence suggests that the
contribution of MSC differentiation is limited because of
poor engraftment and survival of MSCs at the injured site, and
paracrine signaling is the primary mechanism accounting for
the beneficial effects of MSCs on tissue regeneration
(Gnecchi et al., 2008; Herdrich et al., 2008; Hocking
and Gibran, 2010). MSCs secreted various cytokines and
chemokines, vascular endothelial growth factor, IGF-1,
keratinocyte (KC) growth factor, angiopoietin-1, stromal
cell-derived factor-1, and macrophage inflammatory
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protein-1 (Kinnaird et al., 2004; Chen et al., 2008;
Wu et al., 2010). MSC-conditioned medium significantly
promoted endothelial cell tube formation in vitro
(Wu et al., 2007). In addition, MSC-conditioned medium-
stimulated migration of macrophages, KCs, and endothelial
cells in vitro and infiltration of monocytes/macrophages
into wounds (Chen et al., 2008), suggesting a pivotal
role of MSC-derived paracrine factors in cutaneous wound
healing.
Human adipose tissue-derived MSCs (ASCs) exhibit
differentiation potential similar to that of bone marrow-
derived MSCs (Zuk et al., 2002). ASCs represent a population
of cells surrounding adipocytes in fat tissue (Planat-Benard
et al., 2004). ASCs can be easily isolated from subcutaneous
adipose tissue of patients (Zuk et al., 2002); therefore, they
are regarded as an excellent tool for use in tissue regeneration
(Chamberlain et al., 2007; Phinney and Prockop, 2007;
Schaffler and Buchler, 2007). Transplantation of ASCs
enhances postischemic neovascularization and cutaneous
wound healing (Planat-Benard et al., 2004; Ebrahimian et al.,
2009). ASCs have been reported to promote tissue regenera-
tion and angiogenesis within injured or inflamed tissues by
secretion of various cytokines and chemokines, including
vascular endothelial growth factor, stromal cell-derived
factor-1, and IL-6 (Phinney and Prockop, 2007; Ebrahimian
et al., 2009). Co-transplantation of platelet-rich plasma
together with ASCs stimulated wound-healing properties of
ASCs in a porcine full-thickness wound model (Blanton et al.,
2009), suggesting stimulation of ASC-mediated wound
healing by trophic factors produced during the wound-
healing process.
Production of TNF-a by a variety of cells including
macrophages, monocytes, and mast cells during the inflam-
matory phase of wound healing has been reported (Locksley
et al., 2001; Saika, 2007). TNF-a is the proinflammatory
signals controlling wound healing, in a manner that is
dependent on concentration and duration of exposure in
inflamed or injured tissues (Saika, 2007). TNF-a also works in
a paracrine manner, increasing MSCs migration toward
chemokines and elevating invasive levels of MSCs by
stimulation of expression of matrix metalloproteases
(Ponte et al., 2007; Ries et al., 2007). Using shotgun
proteomic technology, we have previously identified 118
individual proteins as TNF-a-induced secreted proteins,
including IL-6, IL-8, monocyte chemotactic protein-1,
CXCL6, cathepsin L, and pentraxin-related protein 3 (Lee
et al., 2010). TNF-a-conditioned medium (CM) stimulated
chemotactic migration of human monocytes in vitro through
mechanisms involving IL-6 and IL-8. These results suggest the
possibility that TNF-a-stimulated secretion of paracrine
factors from ASCs may modulate regeneration of injured
tissues in vivo.
In the present study, to explore the paracrine functions of
TNF-a-stimulated ASCs on tissue regeneration, we examined
the effects of TNF-a CM on cutaneous wound healing in a rat
excisional cutaneous wound model and characterized the
molecular mechanisms by which TNF-a-conditioned med-
ium regulates wound repair in vivo.
RESULTS
TNF-a CM accelerates re-epithelialization and wound closure
in vivo
To determine whether or not TNF-a can regulate the
paracrine function of ASCs, the effects of TNF-a CM, which
was derived from ASCs, on tissue regeneration were
determined using an excisional cutaneous wound-healing
model. Compared with PBS- or control CM-treated wounds,
topical application of TNF-a CM onto cutaneous wounds
accelerated wound closure (Figure 1a). Wound areas were
time-dependently diminished under all experimental condi-
tions, whereas TNF-a CM-stimulated decrease of wound area
became more evident on day 6 or 9 (Figure 1b). Histological
analysis of wounds showed that TNF-a CM accelerated re-
epithelialization and wound closure, compared with PBS- or
control CM-treated wounds (Figure 1c and Supplementary
Figure S1 online).
TNF-a CM stimulates angiogenesis within cutaneous wounds
Angiogenesis is implicated in tissue regeneration and wound
healing (Li et al., 2003b). To elucidate the role of TNF-a CM
on angiogenesis, we determined the number of blood vessels
within cutaneous wounds after treatment with TNF-a CM. As
shown in Figure 2a, the numbers of blood vessels containing
red blood cells were augmented in TNF-a CM-treated
wounds, suggesting enhanced angiogenesis during TNF-a-
stimulated wound repair. To further confirm the result that
TNF-a CM-stimulated angiogenesis, capillary densities in
wounds were quantified by immunostaining of tissue sections
for the endothelial cell-specific marker von Willebrand factor
(vWF). Compared with PBS- or control CM-treated wounds,
the number of blood vessels composed of vWF-positive
endothelial cells was increased in TNF-a CM-treated wounds
(Figure 2b). Capillary densities containing vWF-positive
endothelial cells within cutaneous wounds were time-
dependently increased in response to TNF-a CM treatment,
with a maximal increase on day 6 (Figure 2c), and decreased
to control levels by day 12. These results suggest that TNF-a
CM stimulates angiogenesis in an early phase of the
cutaneous wound-healing processes.
TNF-a CM increases accumulation of macrophages and cell
proliferation during wound healing
Infiltration of monocytes/macrophages normally occurs dur-
ing an early step of the wound-healing processes and is
required for regeneration of injured tissues (Martin and
Leibovich, 2005; Adamson, 2009). We have reported that
TNF-a CM contains various cytokines and chemokines, and
enhances chemotactic migration of human monocytes
in vitro (Lee et al., 2010). To clarify whether or not TNF-a
CM can enhance infiltration of monocytes/macrophages into
cutaneous wounds, immunostaining with an antibody against
monocyte/macrophage-specific marker CD68 was per-
formed. As shown in Figure 3a, the number of CD68-positive
cells was significantly increased in TNF-a CM-treated
wounds, compared with PBS- or control CM-treated wounds.
Similar to TNF-a CM-stimulated angiogenesis, TNF-a CM-
stimulated infiltration of CD68-positive cells peaked on day 6
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and decreased to control levels on day 9 (Figure 3b). These
results suggest that TNF-a CM stimulates infiltration of
monocytes/macrophages into cutaneous wounds.
To assess the effect of TNF-a CM on cell proliferation
during wound healing, we determined the number of
proliferating cells by immunofluorescence staining of the
Ki67 antigen, which is a nuclear protein associated with cell
proliferation (Schonk et al., 1989). Immunofluorescence
staining of wounds on day 6 showed an increase in number
of Ki67-positive cells within the dermal area in response to
treatment with TNF-a CM (Figure 3c). Quantification of the
immunostaining results showed a significant increase in the
number of Ki67-positive proliferating cells on day 6 after
topical application of TNF-a CM onto cutaneous wounds,
compared with control CM (Figure 3d).
TNF-a CM stimulates cutaneous wound healing through
IL-6- and IL-8-dependent mechanisms
We have reported that both IL-6 and IL-8 are largely
responsible for TNF-a CM-stimulated chemotaxis of mono-
cytes in vitro (Lee et al., 2010). To determine whether or not
these cytokines are responsible for TNF-a CM-stimulated
cutaneous wound healing, IL-6 and IL-8 were depleted from
TNF-a CM by immunoprecipitation with anti-IL-6 and anti-
IL-8 antibodies. As shown in Figure 4a, IL-6 and/or IL-8 were
specifically depleted from TNF-a CM by immunoprecipita-
tion with a combination of anti-IL-6 and anti-IL-8 antibodies,
respectively. Because TNF-a CM-stimulated wound closure
peaked on day 6, we next explored the effects of IL-6- or IL-8-
depleted TNF-a CM on wound healing on day 6. TNF-a CM-
stimulated re-epithelialization and wound closure were
completely attenuated by depletion of IL-8 or both IL-8 and
IL-6 from TNF-a CM, whereas depletion of IL-6 partially
attenuated TNF-a CM-stimulated re-epithelialization and
wound closure (Figure 4b and c and Supplementary Figure
S2 online). These results suggest that IL-6 and IL-8 are largely
responsible for TNF-a CM-stimulated cutaneous wound
healing.
IL-6 and IL-8 are involved in TNF-a CM-induced angiogenesis
in vivo
To explore the question of whether or not IL-6 and IL-8 are
involved in TNF-a CM-stimulated angiogenesis, we exam-
ined the effects of IL-6- or IL-8-depleted TNF-a CM on
angiogenesis during cutaneous wound healing. As shown in
Figure 5a, TNF-a CM-stimulated formation of blood vessels
containing red blood cells was markedly diminished by
depletion of IL-6 or IL-8. Depletion of IL-6 or IL-8 consistently
attenuated the TNF-a CM-stimulated increase of vWF-
positive blood vessels (Figure 5b and c). In addition,
depletion of both IL-6 and IL-8 from TNF-a CM completely
abrogated TNF-a CM-stimulated angiogenesis (Figure 5c),
suggesting a principal role for IL-6 and IL-8 in TNF-a CM-
stimulated angiogenesis.
IL-6 and IL-8 are involved in TNF-a CM-induced infiltration
of macrophages and cell proliferation during wound healing
To evaluate the question of whether or not IL-6 and IL-8 are
responsible for TNF-a CM-induced infiltration of macro-
phages into cutaneous wounds, we determined the number of
macrophages in dermal wounds that were treated with IL-6-
or IL-8-depleted TNF-a CM. Compared with control wounds
which were treated with TNF-a CM, the number of CD68-
positive cells was markedly reduced in dermal wounds
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Figure 1. Effects of tumor necrosis factor (TNF)-a-conditioned medium (CM) on cutaneous wound healing and re-epithelialization. (a) Excisional wounds
were treated daily with phosphate-buffered saline (PBS), control CM, or TNF-a CM and photographed at the time indicated from days 0–12 (n¼ 8 for each
group and time point). Representative photographs of wounds are shown. (b) Measurement of wound sizes at different time points after wound injury.
Areas of the wounds were determined by quantitative analysis of wound images using Image J software. Analysis of variance (ANOVA), *Po0.05 versus
control CM (n¼16). (c) Histomorphometric analysis of wound gap, which was determined by measurement of the distance between the advancing
edges of keratinocytes in the wounded epidermis shown in Supplementary Figure S1 online. ANOVA, *Po0.05 versus control CM (n¼16).
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treated with IL-6- or IL-8-depleted TNF-a CM (Figure 6a
and b). Depletion of IL-8 or both IL-8 and IL-6 completely
inhibited infiltration of CD68-positive cells in response
to TNF-a CM, whereas depletion of IL-6 partially reduced
TNF-a CM-induced infiltration of CD68-positive cells.
These results suggest a principal role for IL-8 in TNF-a CM-
stimulated infiltration of macrophages into dermal wounds.
We next explored the question of whether or not IL-6 and
IL-8 are involved in TNF-a CM-stimulated cell proliferation
during wound healing by immunofluorescence staining with
anti-Ki67 antibody. Immunofluorescence staining of dermal
wounds showed that depletion of IL-6 and/or IL-8 markedly
attenuated the TNF-a CM-stimulated increase of Ki67-
positive cells within dermal wounds on day 6 (Figure 6c
and d). These results suggest that IL-6 and IL-8 are largely
responsible for cell proliferation associated with TNF-a CM-
stimulated wound healing.
DISCUSSION
We presently showed that TNF-a CM accelerated re-
epithelialization, angiogenesis, infiltration of macrophages,
and proliferation within cutaneous wounds. Compared with
the potent stimulation of cutaneous wound healing by TNF-a
CM, control CM from ASCs had no significant impact on
cutaneous wound healing. Stimulation of cutaneous wound
healing by MSC-conditioned medium, which was prepared
by exposure of MSCs to hypoxic condition and further
concentrated to 50 times by ultrafiltration, has been demon-
strated (Chen et al., 2008). Treatment of MSCs with hypoxic
conditions led to increased secretion of various angiogenic
cytokines and chemokines. In the present study, we prepared
control CM by treatment of ASCs with serum-free medium
under normoxic conditions and directly applied control CM
to wounds without further concentration of conditioned
medium. Therefore, it is likely that low concentration of
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Figure 2. Histological analysis of tumor necrosis factor (TNF)-a-conditioned medium (CM)-induced angiogenesis. (a) Cutaneous wounds on day 6 were
stained with hematoxylin and eosin (H&E) and photographed with a digital camera (at 400) mounted on a light microscope. Yellow arrows indicate
blood vessels containing red blood cells. Bar¼ 50mm. (b) For immunostaining of von Willebrand factor (vWF)-positive blood vessels (green), cutaneous
wounds on day 6 were stained with anti-vWF antibody and probed with Alexa Fluo488 anti-rabbit secondary antibody, and nuclei (blue) were
counterstained with 40-6-diamidino-2-phenylindole (DAPI). Bar¼ 100mm. (c) The number of vWF-positive blood vessels in each section was counted
at the indicated time points. Results are presented as the number of blood vessels per mm2. Analysis of variance, *Po0.05 versus control CM (n¼ 16).
PBS, phosphate-buffered saline.
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paracrine factors in control CM may be responsible for no
effects of control CM on cutaneous wound healing. In
contrast, high concentration of paracrine factors in TNF-a CM
suggests that TNF-a CM will be highly useful for wound
repair and tissue regeneration.
We demonstrated here that IL-6 and IL-8 are largely
involved in TNF-a CM-stimulated cutaneous wound healing.
Protein levels of IL-6 and IL-8 were hardly detected in control
CM and TNF-a treatment drastically upregulated secretion of
IL-6 and IL-8 from ASCs (Figure 4a). Using liquid chromato-
graphy-coupled with tandem mass spectrometry analysis,
we reported that TNF-a CM contained various cytokines
and chemokines, including IL-6 and IL-8, CXCL2, CXCL5,
CXCL6, CXCL10, monocyte chemotactic protein-1, matrix
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Figure 3. Tumor necrosis factor (TNF)-a-conditioned medium (CM) enhances infiltration of macrophages and cell proliferation in cutaneous wounds.
(a) Macrophages within cutaneous wounds were detected by immunostaining with anti-CD68 antibody on day 6. Bar¼100 mm. (b) CD68-positive cells in
each section were counted at the indicated time points. Analysis of variance, *Po0.05 versus control CM (n¼16). (c) To determine the effect of TNF-a CM
on cell proliferation, wound tissues on day 6 were immunostained with anti-Ki67 antibody (green) and nuclei were counterstained with 40-6-diamidino-
2-phenylindole (DAPI) (blue). Bar¼100 mm. (d) Numbers of Ki67-positive cells and nuclei per field were counted and expressed as the relative percentage
of Ki67-positive cells per total cells. Analysis of variance, *Po0.05 versus control CM, (n¼ 16). PBS, phosphate-buffered saline.
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Figure 4. Tumor necrosis factor (TNF)-a-conditioned medium (CM) enhances cutaneous wound healing and re-epithelialization through an IL-6- and
IL-8-dependent mechanism. (a) TNF-a CM was treated with protein G-agarose beads immobilized with control antibody (normal mouse IgG) or anti-IL-6
and/or anti-IL-8 antibodies for immunoprecipitation of IL-6 and/or IL-8. Concentrations of IL-6 and IL-8 in supernatants were determined by ELISA analysis.
(b) Wounds were treated daily with control CM, TNF-a CM, or IL-6- and/or IL-8-depleted TNF-a CM. Wound areas were determined by quantitative analysis
of the wound images on day 6 after wound injury. (c) The gap of wounds was determined by measurement of the distance between the advancing edges of
keratinocytes in the wounded epidermis, as shown in Supplementary Figure S2 online. Analysis of variance, *Po0.05 versus control CM (n¼ 16).
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metalloprotease-1, plasminogen activator inhibitor-1, cathe-
psin L, pentraxin-related protein 3, and complement factors
(Lee et al., 2010). Not only cytokines and chemokines, but
also matrix metalloproteases and plasminogen activator
inhibitors are required for cutaneous wound healing (Lijnen,
2005). Moreover, TNF-a treatment has been shown to
stimulate secretion of vascular endothelial growth factor,
hepatocyte growth factor, and insulin-like growth factor I
from ASCs (Wang et al., 2006). Therefore, it is conceivable
that proteases, growth factors, and other paracrine factors
may also be key players in TNF-a CM-facilitated wound-
healing processes in concert with IL-6 and IL-8, albeit the role
of these TNF-a-secreted proteins in wound healing should be
further explored. Furthermore, it is possible to hypothesize
that exogenously added TNF-a can directly affect wound-
healing processes because TNF-a CM contains a significant
amount of exogenously added TNF-a (Supplementary Figure
S3A online), although TNF-a was not detected in TNF-a CM
by proteomic analysis (Lee et al., 2010). However, this
possibility can be excluded because immunodepletion of
exogenously added TNF-a had no impact on TNF-a CM-
stimulated wound-healing processes; wound closure, angio-
genesis, and infiltration of immune cells (Supplementary
Figure S3 online). Taken together, these results suggest that
TNF-a greatly potentiates the paracrine functions of ASCs in
cutaneous wound healing through stimulation of secretion of
IL-6, IL-8, and other paracrine factors.
Inflammatory cells have a key role in cutaneous wound
healing by cleaning up bacteria and tissue debris from the
wound (Martin and Leibovich, 2005). Leukocytes (neutro-
phils, macrophages, mast cells, and lymphocytes) infiltrate
wound tissue and regulate healing processes (Singer and
Clark, 1999). Conditioned medium from bone marrow-
derived MSCs exposed to hypoxic conditions stimulated
cutaneous wound healing by recruitment of macrophages
and endothelial lineage cells into the wound (Wu et al.,
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Figure 5. Effects of IL-6- or IL-8-depleted tumor necrosis factor (TNF)-a-conditioned medium (CM) on angiogenesis. (a) Cutaneous wounds (Figure 4)
were stained with hematoxylin and eosin (H&E) and photographed with a digital camera at 400 on day 6. Yellow arrows indicate blood vessels containing
red blood cells. Bar¼50 mm. (b) For immunostaining of von Willebrand factor (vWF)-positive blood vessels (green), cutaneous wounds on day 6 were stained
with anti-vWF antibody and probed with Alexa Fluo488 anti-rabbit secondary antibody, and nuclei (blue) were counterstained with 40-6-diamidino-
2-phenylindole (DAPI). Overlaid images are shown. Bar¼100 mm. Representative data from eight animals per group are shown. (c) The number of
vWF-positive blood vessels per mm2 was quantified on day 6. Analysis of variance, *Po0.05 versus control CM, (n¼ 16).
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2007; Chen et al., 2008). In the present study, we
demonstrated that depletion of IL-6 or IL-8 largely attenuated
TNF-a CM-induced infiltration of CD68-positive macro-
phages into cutaneous wounds. Furthermore, depletion of
IL-6 or IL-8 abrogated TNF-a CM-stimulated in vitro chemo-
taxis of human monocytes (Lee et al., 2010), which develop
into macrophages within injured tissues. IL-6 functions as a
chemoattractant for monocytes (Clahsen and Schaper, 2008).
IL-8 was identified as the major bioactive chemoattractant for
neutrophils, which arrive first in the wound. IL-8 is increased
during TNF-a-induced inflammatory responses and recruits
monocytes and neutrophils to the inflamed area (Mukaida,
2000). Therefore, these reports support the notion that IL-6
and IL-8 are key players in TNF-a CM-stimulated infiltration
of macrophages in vivo.
IL-6 is produced by a variety of cells in wounds, such as
epidermal KCs, dermal fibroblasts, and macrophages, which
are related to wound healing (Mateo et al., 1994). IL-6
stimulated proliferation of KCs in vitro (Grossman et al.,
1989) and in vivo (Sawamura et al., 1998), which is
associated with re-epithelialization of wounds. Use of a
full-thickness biopsy wounding model on IL-6 knockout
mice provided functional evidence of a role for IL-6 in wound
healing (Gallucci et al., 2000; Lin et al., 2003); IL-6 knock-
out mice exhibited delayed wound healing, which is caused
by impaired re-epithelialization, angiogenesis, leukocyte
infiltration, and collagen accumulation. In addition, IL-8
has a key role in cutaneous wound healing (Gillitzer and
Goebeler, 2001). IL-8 promoted chemotaxis and proliferation
of KCs (Tuschil et al., 1992). IL-8 is highly expressed in
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Figure 6. Roles of IL-6 and IL-8 in the tumor necrosis factor (TNF)-a-conditioned medium (CM)-induced infiltration of macrophages and cell proliferation.
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human wound fluid and in vivo topical application of IL-8 on
human skin grafts in a chimeric mouse model induced re-
epithelialization by stimulation of KC proliferation (Renne-
kampff et al., 2000). IL-8 directly enhanced endothelial cell
survival, proliferation, and angiogenesis (Li et al., 2003a).
These results support the notion that IL-6 and/or IL-8 may be
responsible for TNF-a CM-induced wound healing by directly
stimulating infiltration of macrophages, re-epithelialization,
angiogenesis, and cell proliferation. Because these responses
sequentially occurred during wound-healing processes, an-
other possible explanation is that IL-6 and/or IL-8 affect one
of wound healing step, which stimulates other steps. For
instance, inflammation and accumulation of macrophages
are essential for normal wound healing and occur in advance
of re-epithelialization, angiogenesis, and proliferation during
wound-healing processes (Singer and Clark, 1999). Macro-
phages have a pivotal role in wound healing by not only
cleaning bacteria and damaged tissues, but also secreting
angiogenic cytokines and growth factors. Therefore, it is
suggested that macrophage activation induced by IL-6 and/or
IL-8 indirectly modulates TNF-a CM-stimulated wound
healing by acceleration of wound healing-associated sequen-
tial steps, including re-epithelialization, angiogenesis,
and cell proliferation. The molecular mechanism by which
TNF-a CM stimulates cutaneous wound healing should be
clarified further.
MATERIALS AND METHODS
Materials
a-Minimum essential medium, trypsin, and fetal bovine serum were
purchased from Invitrogen (Carlsbad, CA). Human recombinant
TNF-a was purchased from R&D Systems (Minneapolis, MN). ELISA
kits and neutralizing antibodies for human IL-6 and IL-8 were
purchased from BD Biosciences (Bedford, MA). Normal mouse IgG
was purchased from Millipore (Billerica, MA). Peroxidase-labeled
secondary antibodies were purchased from Amersham Biosciences
(Buckinghamshire, UK).
Cell culture and preparation of conditioned medium
ASCs were isolated from human subcutaneous adipose tissue,
which was obtained from elective surgeries with patient’s
consent and TNF-a CM was prepared from ASCs as previously
described (Lee et al., 2010). Details are available in Supplementary
Text online.
Immunodepletion of IL-6 or IL-8 from TNF-a CM
IL-6 or IL-8 was immunodepleted from TNF-a CM by immunopre-
cipitation with anti-IL-6 or anti-IL-8 antibodies. Details are available
in Supplementary Text online.
Cutaneous wound-healing model
Animal experiments were conducted using protocols approved by
the Pusan National University Institutional Animal Use and Care
Committee. Male Sprague–Dawley rats weighing 275–300 g were
randomly divided into three groups (eight mice per group) and
anesthetized using an intraperitoneal injection of ketamine
(50mg kg1) and xylazine (5mg kg1). Details are available in
Supplementary Text online.
Immunocytochemistry and histological analysis
Animals were killed and skin samples including the wound and the
surrounding skin were excised. Tissue specimens (n¼ 16 per group)
were fixed in 3% paraformaldehyde for 24 hours and embedded in
paraffin. Before sectioning and histological analysis, blocks were cut
to expose wounded tissue near the center of each wound. In the
present study, three consecutive 6mm-thick serial sections from the
center of the wounds were stained with hematoxylin and eosin for
histological analysis. Under light microscopy, the sections were
photographed using a model DFC300FX mounted digital camera
(Leica, Solms, Germany). Gap of wounds, which was defined as the
distance between the advancing edges of KC migration, was
measured in three serial sections using Image J software. Capillary
density and the numbers of proliferating cells and immune cells were
assessed morphometrically by immunostaining with anti-vWF, anti-
Ki67, and anti-CD68 antibodies, respectively. The numbers of
capillary density and Ki67- or CD68-positive cells in three
consecutive serial sections were quantified and averaged. To get a
more accurate view of the wound, two 6mm-thick sections were
taken from the specimens at 150mm intervals and similar results
were obtained after hematoxylin and eosin staining and immuno-
staining of the sections (data not shown). Details are available in
Supplementary Text online.
ELISA
Concentrations of IL-6 and IL-8 in conditioned medium from ASCs
were determined by ELISA analysis. Details are available in
Supplementary Text online.
Statistical analysis
Results of multiple observations are presented as mean±SD. For
multivariate data analysis, group differences were assessed using
one-way or two-way analysis of variance, followed by post hoc
comparisons tested using Scheffe’s method. A value of Po0.05 was
considered significant.
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